TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now' Apr 28, 2026 11:46AM
BridgeBio to Participate in March Investor Conferences Feb 23, 2026 07:30AM
TD Cowen comments on BridgeBio Pharma following positive infigratinib data Feb 12, 2026 07:56AM
TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO) Jan 12, 2026 01:42PM
BridgeBio Pharma (BBIO) PT Raised to at TD Cowen as 'Attruby Beats Expectations Again' Oct 30, 2025 09:39AM


Sep 10, 2025 02:38PM TD Cowen on BridgeBio Pharma (BBIO): 'We anticipate an approval in 2026 with peak sales approaching $1B'
Aug 6, 2025 01:51PM TD Cowen on BridgeBio Pharma (BBIO): 'Attruby Is a Winner'
Mar 10, 2025 08:02AM Deep Track Capital Sends Letter to Dynavax Technologies’ (DVAX) Board
Mar 10, 2025 08:00AM Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
Nov 25, 2024 09:18AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Aug 30, 2024 10:57AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 24, 2024 11:41AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 10, 2024 12:08PM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 25, 2023 07:31AM BridgeBio Pharma Inc. (BBIO) Announces $250 Million Private Placement Equity Financing
Sep 25, 2023 07:30AM BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
Feb 8, 2023 07:30AM BridgeBio Pharma to Participate in February and March Investor Events
Feb 8, 2023 07:30AM BridgeBio Pharma to Participate in February and March Investor Events
Feb 21, 2020 07:25PM BridgeBio Pharma And Eidos Therapeutics To Present At Upcoming Investor Conferences
Feb 21, 2020 07:25PM BridgeBio Pharma And Eidos Therapeutics To Present At Upcoming Investor Conferences